Tirzepatide Lyophilized High Purity 99% Peptide Powder TR 10mg 15mg 20mg 30mg kwa vial maka ọbara shuga / ọrịa shuga.

Tirzepatide bụ glucose-based insulinotropic polypeptide/glucagon-like peptide 1 (GLP-1) agonist anabatara na United States dị ka ihe mgbakwunye nri na mmega ahụ iji melite njikwa glycemic na ndị okenye nwere ụdị ọrịa shuga 2 na nyocha maka iji ya na njikwa ibu na-adịghị ala ala, nnukwu ọrịa obi na-adịghị mma na njikwa nke ọnọdụ ndị ọzọ, gụnyere nkụchi obi na enweghị nkụda mmụọ. steatohepatitis na-abụghị mmanya. Emebere usoro nnwale ụlọ ọgwụ nke 3 SURPASS 1-5 iji chọpụta ịdị mma na nchekwa nke tirzepatide subcutaneously a gbanyere otu izu kwa izu (5, 10 na 15 mg), dị ka monotherapy ma ọ bụ ọgwụgwọ ngwakọta, n'ofe ụdịdị ndị mmadụ nwere ụdị ọrịa shuga 2. Eji tirzepatide mee ihe na ọmụmụ ụlọ ọgwụ jikọtara ya na mbelata haemoglobin glycated (-1.87 ruo -2.59%, -20 ruo -28 mmol/mol) na ịdị arọ ahụ (-6.2 ruo -12.9 n'arọ), yana mbelata nke paramita na-ejikọta ya na nnukwu ihe egwu cardiometabolic dị elu dị ka ọbara mgbali elu, visceral triglycerides. A nabatara Tirzepatide nke ọma, yana obere ihe ize ndụ nke hypoglycemia mgbe ejiri ya na-enweghị insulin ma ọ bụ insulin secretagogues wee gosipụta profaịlụ nchekwa n'ozuzu ya na klas GLP-1 agonist. N'ihi ya, ihe akaebe sitere na nnwale ụlọ ọgwụ ndị a na-egosi na tirzepatide na-enye ohere ọhụrụ maka mbelata haemoglobin glycated nke ọma na ịdị arọ ahụ na ndị okenye nwere ụdị ọrịa shuga 2.